跳至主要内容
临床试验/ACTRN12619000364178
ACTRN12619000364178尚未招募4 期

A Prospective, Randomised, Controlled Trial to Determine if the Addition of Intrathecal Morphine to Local Anaesthetic Infiltration Improves Analgesia and Patient Outcomes Following Primary, Unilateral Knee Replacement

Mater and St Vincents Health0 个研究点目标入组 64 人开始时间: 2019年3月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • Elective primary unilateral total knee arthroplasty
  • Age 40-75 years
  • Ability to self mobilise

排除标准

  • Previous involvement in this study.
  • Neuropathic pain or opioid tolerance (defined as use of >30mg oral morphine/day or
  • equivalent – fentanyl patch 12mcg/hr, buprenorphine patch 20mcg/hr, oral oxycodone
  • >20mg/day)
  • History of stroke or major neurological deficit, sensory and motor disorders in the
  • operated limb
  • Contraindication to spinal anaesthesia (including coagulopathy, sepsis, local infection,
  • patient refusal, spinal defects, previous laminectomy, use of anticoagulant/antiplatelet
  • medications as per ASRA guidelines)
  • Contraindication to any of the study drugs (including allergy, significant renal or
  • hepatic disease, NSAID induced asthma)

研究者

发起方
Mater and St Vincents Health

相似试验